Realtime Foreign Exchange › Gold Spot (FOREX:XAUUSDO)
1203.240 -10.710 (-0.88%)
2014-10-30 09:40:29, 0 min delay
Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.
How the open can make or break your day
1 hour, 40 minutes ago
World Cup Questions Answered
20 hours ago
Oil Prices Are At Two-Year Lows - Should You Buy Now?
1 day ago
Today's Financial News
2 hours, 26 minutes ago
DUBLIN, Ohio (AP) _ Cardinal Health Inc. (CAH) on Thursday reported fiscal first-quarter earnings of $266 million. On a per-share basis, the Dublin, Ohio-based company said it had net income of 78 cents. Earnings, adjusted for amortization costs and non-recurring costs, came to $1 per share. The results exceeded Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 97 cents per share.
2 hours, 28 minutes ago
BEIJING (AP) — Chinese computer maker Lenovo Group has completed its acquisition of Motorola Mobility from Google Inc. in a move aimed at becoming a global smartphone brand. Google bought Motorola Mobility in 2012 for $12.4 billion but appeared to decide quickly the purchase was a mistake. It sold its set-top operations to Arris Group Inc. for $2.35 billion and its smartphone assets, along with some 2,000 patents, to Lenovo.
2 hours, 28 minutes ago
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter. The Lionville, Pennsylvania-based company said it had net income of 43 cents per share. Earnings, adjusted for pretax expenses, were 44 cents per share. The medical device company posted revenue of $355.9 million in the period.
2 hours, 30 minutes ago
CHESTERBROOK, Pa. (AP) _ Auxilium Pharmaceuticals Inc. (AUXL) on Thursday reported a third-quarter loss of $32.7 million. The results topped Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 12 cents per share. The biopharmaceutical company posted revenue of $109.6 million in the period, also topping Street forecasts. Analysts expected $101.5 million, according to Zacks.